The Microbiome and Vaccine Response
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: 2605079
Grant search
Key facts
Disease
EbolaStart & end year
20212025Known Financial Commitments (USD)
$0Funder
UK Research and Innovation (UKRI)Principal Investigator
N/A
Research Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The human gut harbours a complex microbial ecosystem that plays an important role in shaping the host immune system. One area that has yet to be fully explored is the ability of the gut microbiome to influence the efficacy of T cell vaccines through direct, or indirect influences on CD8+ T cell responsiveness. This studentship will seek to understand and exploit the ability of commensal gut microbes to influence the human immune response to T cell vaccination. This is an interdisciplinary project that will begin by combining trials of viral vaccines (e.g. HIV and Ebola vaccines) with in-depth multi-omic analysis to identify functional variation in the gut microbiome associated with immunological markers of vaccine success. It will progress to using in vivo models to study the potential of specific microbes (or microbial products) as adjuvants to improve T cell vaccine response. The studentship will develop interdisciplinary skills in immunology, computational biology, and use of in vivo models as a basis for studying immune-gut microbiome interaction.